https://biotechmorning.com/news/novartis-kills-fabhalta-kidney-trial-strategic-reasons Biotech Morning en 2026-10-17T14:14:57.801Z Novartis Just Killed a Trial of Its Own Blockbuster Drug. Nobody Knows Why. https://biotechmorning.com/news/fda-approves-enspryng-thyroid-eye-disease-mixed-data Biotech Morning en 2026-10-17T14:14:11.282Z The FDA Just Approved a Drug That Failed One of Its Own Tests https://biotechmorning.com/news/caribou-biosciences-shutdown-crispr-doudna Biotech Morning en 2026-10-17T14:13:24.112Z A Nobel Laureate's Biotech Just Ran Out of Road https://biotechmorning.com/news/astrazeneca-2-billion-summit-therapeutics-cancer-deal Biotech Morning en 2026-10-17T14:12:41.086Z AstraZeneca Just Wrote a $2 Billion Check to a Company Most People Haven't Heard Of https://biotechmorning.com/news/estuary-biotherapeutics-adpkd-gene-therapy-launch Biotech Morning en 2026-10-17T14:11:54.032Z $103M to Fix the Gene That's Slowly Destroying 1 in 1,000 Kidneys https://biotechmorning.com/news/biotech-ipo-drought-over-2026 Biotech Morning en 2026-10-17T14:11:06.404Z Biotech's IPO Drought Is Officially Over. What Broke the Spell? https://biotechmorning.com/news/novo-nordisk-orbis-medicines-oral-cardiometabolic-deal Biotech Morning en 2026-10-17T14:10:19.788Z Novo Nordisk's $1.4 Billion Bet That Pills Can Replace Needles https://biotechmorning.com/news/hhs-ai-clinical-trials-initiative Biotech Morning en 2026-10-17T14:09:33.969Z Uncle Sam Wants AI to Run Your Clinical Trials https://biotechmorning.com/news/shkreli-violates-lifetime-pharma-ban Biotech Morning en 2026-10-16T14:14:58.969Z Pharma's Most Infamous Bad Boy Can't Stop Breaking the Rules https://biotechmorning.com/news/pennsylvania-big-pharma-investment-merck-gsk Biotech Morning en 2026-10-16T14:14:18.386Z Pennsylvania Just Became Big Pharma's Favorite Zip Code https://biotechmorning.com/news/lilly-obesity-pill-european-hurdle Biotech Morning en 2026-10-16T14:13:29.749Z Lilly's Obesity Pill Just Cleared Its Biggest European Hurdle https://biotechmorning.com/news/biotech-seed-funding-drops-2026 Biotech Morning en 2026-10-16T14:12:39.526Z Biotech's Investor Class Is Ghosting Early-Stage Startups https://biotechmorning.com/news/china-biotech-export-controls-window-open Biotech Morning en 2026-10-16T14:11:59.404Z China Just Locked the Vault on Biotech Secrets (But Left a Window Open) https://biotechmorning.com/news/rnai-biggest-problem-200-million-bet-city-therapeutics Biotech Morning en 2026-10-16T14:11:16.955Z RNAi's Biggest Problem Just Got a $200 Million Bet https://biotechmorning.com/news/revita-device-glp1-weight-regain-remain1-results Biotech Morning en 2026-10-16T14:10:24.285Z The Device That Wants to Save You From Your GLP-1 Breakup